For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Pulmocide Limited

USPTO Granted Patents = 22

EPO Patents = 7

Trademarks = 2

Forward Citations = 79

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Kazuhiro Ito (21 out of 49 patents)

Peter Strong (21 out of 38 patents)

Stuart Thomas Onions (15 out of 67 patents)

4. Peter John Murray (14 out of 38 patents)

5. Thomas Christopher Colley (13 out of 14 patents)

6. Mihiro Sunose (13 out of 17 patents)

7. Garth Rapeport (10 out of 11 patents)

8. Simon Fraser Hunt (8 out of 8 patents)

9. Vladimir Sherbukhin (8 out of 8 patents)

10. Daniel William Brookes (8 out of 8 patents)

11. Euan Alexander Fraser Fordyce (7 out of 20 patents)

12. Matthew Stephen Coates (5 out of 5 patents)

13. Matthew McConville (3 out of 3 patents)

14. Osama Suleiman (1 out of 11 patents)

15. John King-Underwood (1 out of 39 patents)

22 patents: Sort by Forward Citations

1. 12491182 - Polymorphs of triazole antifungal compound PC945 (2025-12-09),

2. 12269814 - Process for preparing a compound useful to treat mycoses (2025-04-08),

3. 11661415 - Process for preparing a compound useful to treat mycoses (2023-05-30),

4. 11008307 - Compounds which are used in the preparation of the compound of formula (I) (2021-05-18),

5. 10858345 - Process for preparing a compound useful to treat mycoses (2020-12-08),

6. 10800762 - Compounds which are used in the preparation of the compound of formula (II) (2020-10-13),

7. 10662179 - Process for preparing a compound useful to treat mycoses (2020-05-26),

8. 10626126 - Compounds (2020-04-21),

9. 10513511 - Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereof (2019-12-24),

10. 10487073 - Compounds which are used in the preparation of the compound of formula (I) (2019-11-26),

11. 10472375 - 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative (2019-11-12),

12. 10450304 - Compound useful to treat mycoses (2019-10-22),

13. 10344022 - Compound useful to treat mycoses (2019-07-09),

14. 10280155 - Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereof (2019-05-07),

15. 10273249 - 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative (2019-04-30),

Company Overview

Pulmocide Limited is a biotechnology company based in London, specializing in the development of innovative therapies for respiratory diseases. The organization focuses on advancing treatments for conditions such as asthma and chronic obstructive pulmonary disease (COPD), leveraging cutting-edge research in pharmacology and drug delivery systems. With a commitment to improving patient outcomes, Pulmocide aims to address unmet medical needs through its proprietary technologies and scientific expertise.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#174 in London

#814 in United Kingdom

#28,807 in the World

London, United Kingdom

Pulmocide Limited

Forward Citations = 79

23 inventors:

Kazuhiro Ito (21 out of 49 patents)

Peter Strong (21 out of 38 patents)

Stuart Thomas Onions (15 out of 67 patents)

4. Peter John Murray (14 out of 38 patents)

5. Thomas Christopher Colley (13 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pulmocide Limited. Retrieved from https://idiyas.com/company/pulmocide

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…